Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEIH.L Regulatory News (EIH)

  • There is currently no data for EIH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

1 Jul 2008 07:00

RNS Number : 9730X
Evolvence India Holdings PLC
01 July 2008
 

 

Evolvence India Holdings Announces its Net Asset Value as on 31 March 2008

Company's  net assets are US$ 67.8 million and NAV per share is US$ 1.043

Douglas, Isle of Man: 1 July 2008 - Evolvence India Holdings plc ("EIH" or "the Company"), (AIM: EIH.L.), a fund of funds holding company that focuses on India, today announced its unaudited net asset value of US$ 1.043 per share as at 31 March 2008. 

The Company invests in India through the Evolvence India Fund ("EIF"), the Evolvence India Life Sciences Fund ("EILSF") and the fund managers' network of relationships.

 

Highlights:

The Company's net assets are US$ 67.8 million as at 31 March 2008

NAV per share is US$ 1.043 as at 31 March 2008 

The current NAV per share represents an appreciation of 4.3% from the offering price, although a decline of 10.0% from the NAV per share of US$ 1.158 as at 31 December 2007

Paid a dividend of US$ 0.03 per share for the year ended 31 December 2007

Key Portfolio Updates:

Shriram EPC Limited, one of EIF's underlying funds' portfolio companies, was listed on Bombay Stock Exchange and the National Stock Exchange during February 2008

As at 31 March 2008, the deals in advanced stages for EIF included a co-investment with one of its underlying funds as well as a fund investment in a premier Indian infrastructure focused private equity fund

To date, EIH has committed US$ 70.0 million, of which US$ 50.2 million has been deployed. We have received US$ 3.5 million of distributions and paid dividends of US$ 2.0 million

Khaled Al Muhairy, Chairman, Evolvence India Holdings, commented: 

"Looking back on our first year of operations, we have accomplished all the objectives we initially laid out. Our portfolio, which includes over 90 companies across the Indian economy, has performed above expectations and is delivering significant returns to our investors. We have fully committed the Company's capital and invested into 10 funds and 8 co-investmentsThe robustness of the underlying portfolio is evidenced by the NAV of the Company, which is above its offering price, in spite of the Indian capital markets corrections. 

As an early private equity investor into India, we have a maturing portfolio which is starting to see significant realisationsWe received distributions of US$ 3.5 million last year which allowed us to declare a dividend of US$ 0.03 per share. Given the outlook, we intend to increase our dividend rate in the coming year. This is a clear endorsement of our multi-manager approach, achieving a broad diversification of the Company's portfolio. We are confident that the Company's funds are invested with experienced and successful managers and remain committed to pursuing a policy of superior returns with low downside volatility."

Note: The statement above regarding an increase in the dividend is not, and should not be taken as, a forecast of profits. Payment of any increased dividend is subject to prevailing market conditions and the financial condition and prospects of the Company at that time.

- Ends-

About Evolvence India Holding (EIH):

EIH is promoted by Evolvence Capital Ltd ("Evolvence Capital"), a Dubai based, B.V.I. incorporated, alternative investment firm established in 2000 with a primary investment focus on Gulf Co-operation Council countries and India. Evolvence Capital currently has assets under management of approximately US$ one billion. EIH is an Isle of Man incorporated, private equity fund of funds holding company focused on India.

Contacts:

Evolvence India Holdings plc

Khaled Al Muhairy, Chairman + (9714) 315 81000

Evolvence Capital

Shilpa Mathai, Communications Director + (9714) 315 81000

shilpa@evolvence.com

Fairfax I.S. plc (Broker) 

Ewan Leggat + (44) 207 460 4385

Seymour Pierce (Nominated Advisor)

Jonathan Wright, Director, Corporate Finance + (44) 207 107 8000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVUUUWWMUPRUAG
Date   Source Headline
7th May 202011:49 amRNSResult of EGM and Notice of Cancellation
7th Apr 20207:00 amRNSProposed AIM Cancellation and Notice of EGM
2nd Apr 20205:38 pmRNSReturn of Capital and COVID-19 Update
6th Dec 20197:00 amRNSReturn of Capital
29th Nov 20197:00 amRNSDelisting Update
21st Nov 20197:00 amRNSMarket Update
30th Sep 20194:30 pmRNSInterim Results
30th Jul 201911:15 amRNSResult of AGM
28th Jun 20197:00 amRNSPosting of 2018 Annual Results and Notice of AGM
24th May 20195:53 pmRNSHolding(s) in Company
1st May 20197:00 amRNSReturn of Capital
4th Apr 20195:00 pmRNSSale of RSB and Return of Capital
25th Jan 20197:00 amRNSHolding(s) in Company
21st Jan 20196:13 pmRNSHolding(s) in Company
18th Jan 201911:37 amRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim Results
26th Jul 201811:05 amRNSResult of AGM
28th Jun 20187:00 amRNSPosting of 2017 Annual Report and Notice of AGM
28th Jun 20187:00 amRNSReturn of Capital
20th Mar 20181:00 pmRNSReplacement: Return of Capital
20th Mar 20187:00 amRNSReturn of Capital
29th Sep 20175:17 pmRNSHalf-year Report
29th Sep 20175:13 pmRNSReturn of capital
24th Jul 201710:54 amRNSResults of Annual General Meeting
26th Jun 20176:01 pmRNSDirectorate Change
26th Jun 20176:00 pmRNSPosting of 2016 Annual Report and Notice of AGM
9th Feb 20178:05 amRNSReturn of Capital
26th Jan 20175:08 pmRNSHolding(s) in Company
25th Jan 20179:30 amRNSHolding(s) in Company
5th Jan 20177:00 amRNSUpdate re EIF
30th Sep 20167:00 amRNSHalf-year Report
25th Jul 20161:24 pmRNSResult of AGM
27th Jun 20165:37 pmRNSPosting of Annual Report & Notice of AGM
27th Jun 20167:00 amRNSFinal Results
27th Jun 20167:00 amRNSReturn of Capital
30th Nov 20155:57 pmRNSHolding(s) in Company
30th Sep 20157:00 amRNSInterim Results
30th Jun 201511:53 amRNSResult of AGM
9th Jun 20154:00 pmRNSNotice of AGM
5th Jun 20154:35 pmRNSFinal Results
30th Sep 20147:00 amRNSHalf Yearly Report
14th Jul 20143:19 pmRNSReturn of Capital
30th Jun 201411:57 amRNSResult of AGM
4th Jun 20147:00 amRNSNotice of AGM
3rd Jun 20147:00 amRNSFinal Results
3rd Dec 201311:16 amRNSHolding(s) in Company
2nd Dec 20134:09 pmRNSHolding(s) in Company
28th Nov 20135:14 pmRNSHolding(s) in Company
27th Nov 20133:14 pmRNSSale of Interest in Gland Pharma Limited
22nd Nov 20139:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.